澳大利亚与新西兰肾脏损伤关怀指南:慢性肾脏病患者降尿酸治疗指南的快速制定
为应对澳大利亚肾脏试验网络新发表的临床试验,CARI工作组利用现有系统综述并更新文献,采用CARI/GRADE方法在60天内快速制定指南,强烈推荐不对未接受透析的慢性肾脏病合并无症状高尿酸血症患者使用降尿酸治疗。
要点
- 对未接受透析的慢性肾脏病合并无症状高尿酸血症患者,强烈推荐不使用降尿酸治疗。
- 指南基于现有系统综述并更新文献,由工作组采用CARI/GRADE方法制定。
- 整个指南制定过程在60天内完成,其中工作组会议历时45天。
核心结论
- 强烈推荐不对未接受透析的慢性肾脏病合并无症状高尿酸血症患者使用降尿酸治疗。
- 该快速指南制定方法可能成为一种高效整合现有证据发布指南的新方式。
研究设计与样本
- 指南制定项目:利用现有系统综述作为证据基础,并更新纳入随后发表的临床试验。
- 成立工作组,采用CARI/GRADE方法评审证据并撰写指南,工作组在45天内召开3次会议。
主要发现
- 最终形成对未接受透析的慢性肾脏病合并无症状高尿酸血症患者不使用降尿酸治疗的强烈推荐。
- 由2人在15天内完成现有系统综述的识别、文献检索更新和证据合成。
- 工作组在45天内成立并完成指南撰写,整个指南制定过程共60天。
关键数值与推荐
- 强烈推荐:对未接受透析的慢性肾脏病合并无症状高尿酸血症患者不使用降尿酸治疗。
临床怎么用
- 原文未据此给出具体临床操作推荐,仅复述强烈推荐不对未接受透析的慢性肾脏病合并无症状高尿酸血症患者使用降尿酸治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The slow transformation of new research findings into clinical guidelines is a barrier to providing evidence-based care. The Caring for Australians and New Zealanders with Kidney Impairment (CARI) guidelines are developing models to improve guideline production, one methodology involves more functional concordance between trial groups, such as the Australian Kidney Trials Network (AKTN) and CARI. The objective of this project was to rapidly produce an evidence-based guideline on urate-lowering therapy in patients with chronic kidney disease (CKD), in response to new clinical trial publications on the topic by the AKTN. METHODS: To produce a guideline as rapidly as possible, an existing systematic review was utilized as the evidence base, and then updated with the inclusion of clinical trials that had been published subsequently. A Work Group was convened to review the evidence and compose an appropriate guideline using CARI/GRADE methodology. The group met 3 times over 45 days to formulate the guideline. RESULTS: The result was a strong recommendation against the use urate-lowering therapies in individuals with CKD (not receiving dialysis) and asymptomatic hyperuricemia. The process of identifying an appropriate existing systematic review, updating the literature search, and synthesizing the evidence, was done by 2 individuals over 15 days. The Work Group was formulated and composed the guideline over 45 days. In all, a new guideline incorporating the most up-to-date evidence was formulated in 60 days. CONCLUSION: This method of guideline development represents a potentially new way of releasing guidelines that encapsulates all available evidence in a time-efficient manner.
引用
- Stanley IK, Phoon RKS, Toussaint ND, et al. Caring for Australians and New Zealanders With Kidney Impairment Guidelines: Rapid Development of Urate Lowering Therapy Guidelines for People With CKD. Kidney Int Rep. 2022. PMID: 36506231. doi:10.1016/j.ekir.2022.09.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。